» Articles » PMID: 19842073

DNA Methylation: an Introduction to the Biology and the Disease-associated Changes of a Promising Biomarker

Overview
Journal Mol Biotechnol
Publisher Springer
Date 2009 Oct 21
PMID 19842073
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

DNA methylation occurring on the 5 position of the pyrimidine ring of cytosines in the context of the dinucleotide sequence CpG forms one of the multiple layers of epigenetic mechanisms controlling and modulating gene expression through chromatin structure. It closely interacts with histone modifications and chromatin remodeling complexes to form the genomic chromatin landscape. DNA methylation is essential for proper mammalian development, crucial for imprinting and plays a role in maintaining genomic stability as well as in dosage compensation. DNA methylation patterns are susceptible to change in response to environmental stimuli such as diet or toxins, whereby the epigenome seems to be most vulnerable during early in utero development. Aberrant DNA methylation changes have been detected in several diseases, particularly cancer where genome-wide hypomethylation coincides with genespecific hypermethylation. DNA methylation patterns can be used to detect cancer at very early stages, to classify tumors as well as predict and monitor the response to antineoplastic treatment. As a stable nucleic-acid-based modification with limited dynamic range that is technically easy to handle, DNA methylation is a promising biomarker for many applications.

Citing Articles

Reply to: Validation of blood-based detection of breast cancer highlights importance for cross-population validation.

Wang T, Li P, Qi Q, Li J, Du L, Wang C Nat Commun. 2025; 16(1):2165.

PMID: 40044658 PMC: 11882893. DOI: 10.1038/s41467-025-57266-y.


Molecular characterization of doublesex and Mab-3 (DMRT) gene family in Ctenopharyngodon idella (grass carp).

Parveen S, Khan M, Sultana M, Rehman S, Shafique L J Appl Genet. 2024; .

PMID: 39607661 DOI: 10.1007/s13353-024-00924-6.


Association analysis between an epigenetic alcohol risk score and blood pressure.

Bui H, Keshawarz A, Wang M, Lee M, Ratliff S, Lin L Clin Epigenetics. 2024; 16(1):149.

PMID: 39468603 PMC: 11520477. DOI: 10.1186/s13148-024-01753-4.


Functional Genomics in Psoriasis.

Rossi S, Richards E, Orozco G, Eyre S Int J Mol Sci. 2024; 25(13).

PMID: 39000456 PMC: 11242296. DOI: 10.3390/ijms25137349.


Decoding the role of DNA methylation in allergic diseases: from pathogenesis to therapy.

Han R, Zhu D, Sha J, Zhao B, Jin P, Meng C Cell Biosci. 2024; 14(1):89.

PMID: 38965641 PMC: 11225420. DOI: 10.1186/s13578-024-01270-0.


References
1.
Jones P, Baylin S . The epigenomics of cancer. Cell. 2007; 128(4):683-92. PMC: 3894624. DOI: 10.1016/j.cell.2007.01.029. View

2.
Fraga M, Ballestar E, Paz M, Ropero S, Setien F, Ballestar M . Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A. 2005; 102(30):10604-9. PMC: 1174919. DOI: 10.1073/pnas.0500398102. View

3.
Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

4.
Issa J, Ahuja N, Toyota M, Bronner M, Brentnall T . Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001; 61(9):3573-7. View

5.
Issa J . CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004; 4(12):988-93. DOI: 10.1038/nrc1507. View